TLR4 and its signaling pathways on melanoma cells may be a potential direct target for immuno- and molecular therapy in melanoma patients.
| Project/Area Number |
20790794
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Dermatology
|
|---|
| Research Institution | Shinshu University |
|---|
Principal Investigator |
GOTO Yasufumi Shinshu University, 医学部附属病院, 助教(特定雇用) (60467181)
|
|---|
| Project Period (FY) |
2008 – 2009
|
| Project Status |
Completed (Fiscal Year 2009)
|
| Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2009: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2008: ¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
|
|---|
| Keywords | 皮膚腫瘍学 / 皮膚腫瘍 / メラノーマ / Toll様受容体 / 分子標的薬 / 皮膚科学 / 腫瘍免疫学 |
|---|
| Research Abstract |
TLR activation of tumor cells is suggested to be a factor promoting tumor progression in melanoma. TLR4 and its signaling pathways on melanoma cells may be a potential direct target for molecular therapy in melanoma patients.
|
Report
(3 results)
Research Products
(12 results)
